Decoding Medication Adherence with Jo Halliday, CEO of Talking Medicines

Tired of people not taking their meds? Talking Medicines uses cutting-edge AI to bridge the gap between patients and healthcare professionals, leading to better medication adherence.

Join Philip Crowley as he chats with Jo Halliday, CEO of Talking Medicines, about:
The hidden world of medication non-adherence: Why do a staggering 50% of people skip their meds? Talking Medicines sheds light on the reasons behind this alarming trend using powerful AI tools.
Talking Medicines’ remarkable journey: From a tech consultancy to a leading AI innovator in the life sciences field, Talking Medicines has carved a unique path.
The power of AI for healthcare: Discover how Talking Medicines leverages machine learning and natural language processing to revolutionize medication adherence, improving patient outcomes.
Building a successful tech startup: Jo Halliday shares her hard-won insights on the entrepreneurial rollercoaster, including the challenges, rewards, and importance of pivoting when necessary.
International expansion: Learn about Talking Medicines’ decision to establish a presence in the US market to be closer to key players and enhance client relationships.

Plus, gain valuable insights into Jo’s personal journey and the exciting future of Talking Medicines!

Share This Story

Contact Our Firm

Contact our firm

This field is for validation purposes and should be left unchanged.

Subscribe to Our Newsletter